Skip to main content
Number №4, 2025
Modern trends in the treatment of hypospadias in the Russian Federation Metabolic conditions for the formation of calcium oxalate urinary stones A comprehensive approach to the treatment of chronic encrusting cystitis Voiding diary: clinical significance and prospects for digitalization
Number №3, 2025
First analysis of laboratory adherence in the Russian Federation to the sixth edition of the WHO laboratory manual for the examination and processing of human semen
Number №2, 2025
Post-Void Residual Urine Ratio (PVR-R) as a prognostic marker of chronic kidney disease in men with benign prostate hyperplasia
Number №1, 2025
The effect of testosterone replacement therapy on lower urinary tract symptoms (LUTS) in men
Number №4, 2024
The structure of damage of the genitourinary system in modern armed conflict
Number №3, 2024
Cost-effectiveness of urinary incontinence treatment in a short-stay hospital
Number №2, 2024
Complex medicines for correction of urine pH level during urolithiasis metaphylaxis
Number №1, 2024
Moscow program on histofusion biopsy of the prostate: results of a survey of practicing urologists based on data from a multicenter study
Number №4, 2023
Possibilities for improving the therapeutic activity of bacteriophage preparations Urological complications after renal transplantation
Number №3, 2023
Regulatory and legal possibilities for metaphylaxis of urolithiasis in the Russian Federation
Number №2, 2023
Frequency and nature of symptoms of dysfunction of the lower urinary tract in persons over 40 years old Postcoital cystitis as a cause of sexual dysfunction in women
Number №4, 2022
Surgical treatment of inferior vena cava tumor thrombus X-ray-free ureterolithotripsy for ureteral stones
Number №3, 2022
Brachytherapy for prostate cancer and immune response Risk factors for nephrolithiasis after radical cystectomy with intestinal plasty of the bladder
Number №2, 2022
The incidence of urolithiasis in the Russian Federation from 2005 to 2020 Urolithiasis and the risk of myocardial infarction and stroke
Number №1, 2022
A modern view on the screening of urolithiasis Hereditary factor of metaphylaxis of urolithiasis Treatment of infertility associated with a high level of sperm DNA fragmentation
Number №4, 2021
COVID-19 associated encrusting cystitis Endoscopic correction of vesicoureteral reflux in children: differentiated choice of method, material and dosage
Number №3, 2021
Artificial intelligence in urology oncology Mini-percutaneous nephrolithotomy without ureteral catheterization. Comparison with the standard method
Number №1, 2021
Epidemiological study of the prevalence of cystitis in women in the Voronezh region Congenital anomalies of the penis: world and domestic data
Number №5, 2020
Isolated kidney injury: international guidelines and Moscow standards
Number №3, 2020
Epidemiology of neurogenic urinary disorders. Treatment outcomes for high-risk prostate cancer patients: a multicenter analysis
Number №2, 2020
COVID-19: Impact on the Urological Service of the Russian Federation Genitourinary system and Covid-19: some aspects
Number №1, 2020
Distance education in urology. Experience 2012-2019 Inpatient care for urological patients in the context of the COVID-19 pandemic
Number №4, 2019
Male infertility in the Russian Federation: statistics for 2000-2018 Evaluation of the effectiveness of perineum muscle training in restoring erectile function
Number №3, 2019
Epidemiology of urolithiasis in the Perm region: results of a 30-year study The economic and economic rationale for the use of modern methods of treating urolithiasis
Номер №4, 2018
Incidence of ICD in the Russian Federation (2005-2016) Screening for prostate cancer: modern presentation and organization Primary multiple transitional cell epithelium Androgenic screening in men over 50 years
Номер №3, 2018
The role of stem cells in the treatment of urinary incontinence Percutaneous nephrolithotripsy in infected urine Testicular Prosthesis in Children and Adolescents: Results from a Multicenter Study Premature ejaculation is the current state of the problem.
Number №2, 2018
Alternative methods of treatment of localized prostate cancer Partial doubling of the urethra: paraurethral motion Comparative review of disposable flexible ureteronephroscope
Number №1, 2018
The prevalence of symptoms of impairment of the function of the lower urinary tract in men according to the results of a population study Patient-centered system of organization of medical care in urology using...
Number №4, 2017
Predicting the development of erectile dysfunction and cardiovascular diseases Prognostic factors of survival of patients with prostate cancer
Number №3, 2017
Recommendations for the treatment of prostate cancer with the help of high-power interstitial radiation therapy (brachytherapy)
Number №2, 2017

Radioisotope lymphoscintigraphy with PCa
Metabolic risk factors and formation of urinary stones
Ureteral amputation in the performance of contact ureterolithotrypsy

Number №1, 2017
Principles of «4P Medicine» in the organization of health care in the context of urological diseases Changes in the electrolyte composition of urine under the influence of sodium hypochlorite. The possibility of reducing the risk of recurrence of nephrolithiasis
Number №4, 2016
Preliminary results of a multicenter study of prostate cancer Analysis of specialized medical care for patients with gross hematuria, renal colic.
Number №3, 2016
Techniques for preserving continence after robot-prostatectomy The protective partial nephrectomy for renal cell carcinoma
Number №2, 2016
Медицинская помощь пациентам с острой задержкой мочеиспускания Прогностическое значение истинного кастрационного уровня тестостерона..
Number №1, 2016
The analysis of the accuracy of factors for the survival predictiry after radical cystectomy Citokine status in pathients with recurrent urinary tract infection
Number №4, 2015

Modern demographic situation in Russia Determination of gene mutations FGFR3 and PIK3CA DNA urine sediment from patients with bladder cancerя

Number №3, 2015
Neuroendocrine differentiation in cancer prostate. The role of viruses in carcinogenesis of bladder cancer.
Number №2, 2015
Clinical and economic evaluation of prostate cancer screening The combination RSAZ TMPRSS2-ERG in the diagnosis of prostate cancer: first experience
Number №1, 2015
The role of distance education in improving primary health care professionals. Comparative analysis of the results of cancer radical retropubic and robot-assisted prostatectomy.
Number №4, 2014
Experience of clinical and economical treatment cancer patients Comparison of analysis details for open, laparoscopic and robot-assisted nephrectomy in the..
Number №3, 2014
Medical and economic aspects of a comprehensive standardized program-stage diagnosis and treatment of benign prostatic hyperplasia
Number №2, 2014
Uronephrological morbidity and mortality in Russia in 2002-2012 Androgens and chronic ischemia PCA3 test-system: first results
Number №1, 2014
First results of standardized programme for BPH diagnosis and treatment Evaluation of serum Chromogranin A levels in different prostatic diseases Retarded ejaculation is a rare diagnosis
Number №4, 2013
Distance education in urology brachytherapy prostate cancer Erectile dysfunction and cardiovascular ...
Number №3, 2013
The incidence of kidney stones... HIFU-treatment of local recurrence of cancer... Non-prostatic sources of prostate...
Number №2, 2013
Risk factors for the development
of the urolithiasis in patients
with the metabolic syndrome
Number №1, 2013
Clinical and economic analysis of the surgical treatment of prostate cancer Brachytherapy prostate cancer: postimplantnaya dosimetry and dependence ... Simulation prostatic carcinogenesis
Number №4, 2012
Урологическая заболеваемость в Нижегородской области Стресс, метаболический синдром и хроническая болезнь почек TVT - 10 лет в России
Eksperimental'naya i klinicheskaya urologiya

Peer-Review Policy

1386

Peer Review

A double-blind peer review method is mandatory for processing of all manuscripts submitted to the journal “Experimental and Clinical Urology”. “Experimental and Clinical Urology” performs a peer review of all materials, received by the Editorial Office: editorials, original articles, reviews, clinical cases, and guidelines. Comments and letters to the Editor-in- Chief are not subjected to peer review. Peer reviewing ensures maintaining high quality of the journal’s content and allows assessing the concrete contribution to the development of main research areas on diagnosis, treatment and prevention of cardiovascular diseases.

Initial assessment

Before appointing a reviewer, the Editor-in-Chief and editorial assistant confirm: 1 The compliance of the submitted manuscript to the Aims and Scope of the journal; 2 The accompanying documents and authors’ signatures (see Author Guidelines); 3 The format and structure of the submitted manuscript (see Author Guidelines); 4 The funding statement, conflict of interests, contributions of each author to the submitted manuscript (see Author Guidelines, Conflict of Interest); 5 The compliance of the submitted manuscript to ethical policy of the “Experimental and Clinical Urology” (Approvals obtained from Ethics Committees when publishing the findings of researches on humans or laboratory animals or written informed consent collected from patients when submitting clinical cases); 6 The uniqueness and originality of the manuscript. Incoming material is checked for plagiarism and borrowing (see Author Guidelines).

At the stage of initial evaluation, the submitted material is reviewed by the Editor-in- Chief and editorial assistant and may be returned to the authors for revision. Articles suitable for the further review will be subjected to the evaluation by two independent reviewers. If the submitted material does not correspond to the Aims and Scope of the journal, the Editorial Board may reject the manuscript without conducting a peer review.

Reviewers

Selection All manuscripts submitted to the journal that requires the expert evaluation are subjected to a double-blind peer review. The name of the reviewer can be disclosed at the author’s request. Disclosure of a reviewer’s name does not affect the process and the principle of further work. The name of a reviewer is disclosed by the Editor-in-Chief if the reviewer declares the manuscript to be unreliable or contain falsified information.

All reviewers are acknowledged experts on the subject of the reviewed materials and have publications on the subject of peer-reviewed articles within the last 3 years. All reviews are stored in the publishing and editorial office for 5 years and may be requested by any interested author. The Editor-in-Chief selects independent reviewers from the biomedical community. After agreeing to review a manuscript, the reviewer receives materials for peer reviewing. Manuscripts for review are sent to the reviewer via the electronic manuscript submission system. The peer-reviewing should be performed in 14 days.

Each reviewer must disclose to editors any relationships or activities that could bias his or her opinion of the manuscript, and should recuse himself or herself from reviewing specific manuscripts if the potential for bias exists. Reviewers must not use knowledge of the work they’re reviewing before its publication to further their own interests (see Conflict of Interest). In case the reviewer cannot perform the reviewing, he or she can recommend to the Editor-in-Chief other reviewers in this field of knowledge. Editor-in-Chief, Deputy Editors and Publishing Editor follow the principles and recommendations of the World Organization of Medical Editors on selecting the reviewer.

Peer review of statistics Original research manuscripts containing statistical analysis are sent to the peer review of statistics. The requirements for the description of statistical methods are presented in the rules for authors (see Author Guidelines).

Ethics of Peer Review

The Experimental and Clinical Urology asks the reviewers to follow the basic principles of the Committee on Publication Ethics (COPE):

1) Agree to review manuscripts for which they have the subject expertise required to carry out a proper assessment and which they can assess in a timely manner;

2) Respect the confidentiality of peer review and not reveal any details of a manuscript or its review, during or after the peer-review process, beyond those that are released by the journal;

3) Not use information obtained during the peer-review process for their own or any other person’s or organization’s advantage, or to disadvantage or discredit others; 4) Declare all potentially conflicting interests, seeking advice from the journal if they are unsure whether something constitutes a relevant interest;

5) Not allow their reviews to be influenced by the origins of a manuscript, by the nationality, religious or political beliefs, gender or other characteristics of the authors, or by commercial considerations;

6) Be objective and constructive in their reviews, refraining from being hostile or inflammatory and from making libelous or derogatory personal comments,

7) Acknowledge that peer review is largely a reciprocal endeavor and undertake to carry out their fair share of reviewing and in a timely manner;

8) Provide journals with personal and professional information that is accurate and a true representation of their expertise

9) Recognize that impersonation of another individual during the review process is considered serious misconduct

Reviewer’s report and suggestions

After peer reviewing the manuscript, the reviewer gives his or her report suggesting that: 1) Manuscript may be accepted. Reviewers have no major remarks. The paper is to be handled by a proofreader. The timeline of publication is set by the Editor-in-Chief, Deputy Editors, Publishing Editor and the Editorial Board. 2) Manuscript requires revision. The paper needs minor or major revision and second time reviewing. The corresponding author receives an anonymous reviewers’ comments by email, need to revise paper and then upload revised version to the Journal's site. 3) Manuscript should be rejected. The corresponding author receives a well-argued denial.

The editorial office send copies of reviews or motivated refusals to the authors of the submitted manuscripts, and may send their copies to the Ministry of Education and Science of the Russian Federation upon the corresponding request to the editorial office.

Manuscript revision

If the review contains recommendations for correcting and finalizing the manuscript, the editorial office of the journal sends the reviews to the author for the revision. The revision of the manuscript is limited up to 2 months from the date of sending the electronic message to the corresponding author via email and the electronic system. The revised manuscript is then submitted by the corresponding author for the second-round peer-review.

In case of disagreement with the comments of the reviewer, the author can provide a well-argued answer to the editorial office of the journal. If the author and reviewers have irreconcilable differences concerning the manuscript, the editorial board may send the manuscript to the third reviewer. The decision in conflict situations is made by the Editor-in- Chief.

Refusal to correct a manuscript If the authors decide not to revise their articles, they have to notify the editorial office in writing of their refusal from publishing the manuscript. Should the authors fail to return the revised version within 3 months after receiving the review, even in the absence of the authors’ notice of their refusal to revise the paper, the editorial office will strike it off the register. In such cases, the authors are duly notified that their manuscript will not be published owing to the expiration of the time specified for revision of the paper.

Appeal

The author has a right to lodge an appeal to the Editor-in-Chief during 30 days from the rejection of the article in case if the author doesn’t agree with the decision of the Editorial Office and finds that the article was rejected unfairly. The appeal should include all the comment made by the Editors and Reviewers. The Editor-in-Chief can change initial decision in a case that unfairness of the comments would be proved and/or the Authors would support their point of view. The Editor-in-Chief has a right to appoint the second round reviewing and chooses independent reviewers from national and international biomedical community. If the Editor-in- Chief chooses the Reviewers who are non-Russian speakers, the Editorial Office translates the manuscript free of charge once the Authors’ agreement is received. If the Reviewers recommend the manuscript for the publication and state the previous reviews as unfair, the Editor-in-Chief initializes internal inquiry in competency of the Reviewers and the Publishing Editor with their temporary suspension. The Authors will be notified by written notice about the re-registration of the article.

After the decision on the manuscript publication has been made, the Editorial Office notifies the Author and sets time limits for the publication.

Яндекс.Метрика